The Official Website of the State of West Virginia

Morgantown, West Virginia, based ExesaLibero-Pharma developing next-generation arthritis relief drug


After decades of work in the microbiology field, Dr. John Barnett is hoping to continue his life’s work with a new drug that aims to slow down bone erosion for people with rheumatoid arthritis.

Barnett, the chair of microbiology, immunology and cell biology at West Virginia University, said that thanks to a recent discovery, he founded ExesaLibero-Pharma, a company that aims to slow or stop bone erosion for arthritis patients. The company name itself is Latin for “without erosion.”

Read more: